July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Inhibiting CDS2 Selectively Kills CDS1-deficient Cancer Cells – The Netherlands Cancer Institute
Jul 9, 2025, 01:44

Inhibiting CDS2 Selectively Kills CDS1-deficient Cancer Cells – The Netherlands Cancer Institute

The Netherlands Cancer Institute shared a post on LinkedIn:

Researchers at the Netherlands Cancer Institute have identified a novel vulnerability present in about 50% of cancers. PhD candidate Tim Arnoldus, in the group of Daniel Peeper, took an innovative approach: instead of traditional lab screens, he used large public datasets and advanced computational analyses to pinpoint new cancer dependencies. This led to the discovery of a synthetic lethal interaction between the genes CDS1 and CDS2.

Many aggressive tumors lose CDS1 function and become fully reliant on CDS2 for survival.

Inhibiting CDS2 selectively kills these cancer cells while sparing healthy tissue, a concept similar to how PARP inhibitors work in BRCA-mutated cancers.

The findings, published in Nature Genetics, provide a strong foundation for developing new targeted therapies for difficult-to-treat tumors.

Learn more.”

Inhibiting CDS2

More posts featuring the Netherlands Cancer Institute on OncoDaily.